Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Research & Development: 2019-2024

Historic Research & Development for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to $9.6 million.

  • Biodesix's Research & Development rose 17.47% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 27.79%. This contributed to the annual value of $9.6 million for FY2024, which is 4.30% down from last year.
  • As of FY2024, Biodesix's Research & Development stood at $9.6 million, which was down 4.30% from $10.0 million recorded in FY2023.
  • Over the past 5 years, Biodesix's Research & Development peaked at $13.1 million during FY2022, and registered a low of $9.6 million during FY2024.
  • Over the past 3 years, Biodesix's median Research & Development value was $10.0 million (recorded in 2023), while the average stood at $10.9 million.
  • Per our database at Business Quant, Biodesix's Research & Development increased by 18.22% in 2021 and then decreased by 23.77% in 2023.
  • Over the past 5 years, Biodesix's Research & Development (Yearly) stood at $10.8 million in 2020, then rose by 18.22% to $12.8 million in 2021, then climbed by 2.45% to $13.1 million in 2022, then decreased by 23.77% to $10.0 million in 2023, then dropped by 4.30% to $9.6 million in 2024.